RAPT THERAPEUTICS INC. - COMMON STOCK
4.0400
17-May-24 15:59:56
15 minutes delayed
Stocks
-0.1000
-2.42%
Today's range
4.0300 - 4.2322
ISIN
N/A
Source
NASDAQ
-
RAPT Therapeutics Reports First Quarter 2024 Financial Results
09 May 2024 08:00:01 By Nasdaq GlobeNewswire
-
09 Apr 2024 12:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
07 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
20 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
13 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
31 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
27 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports Third Quarter 2023 Financial Results
13 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in November
01 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
18 Oct 2023 09:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September
30 Aug 2023 16:05:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports Second Quarter 2023 Financial Results
11 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Participate in the Goldman Sachs Global Healthcare Conference
07 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
25 May 2023 17:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports First Quarter 2023 Financial Results
11 May 2023 08:00:02 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Announces the Appointment of Michael Listgarten as General Counsel
03 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
26 Apr 2023 16:19:49 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >